Morgan Stanley
DRMA icon

Morgan Stanley’s Dermata Therapeutics DRMA Stock Holding History

Morgan Stanley’s Portfolio DRMA Stock Details DRMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$230 – 7741
2022
Q4 		– Hold
0
– – – 7630
2022
Q2 		– Hold
0
– – – 7837
2022
Q1 		– Hold
0
– – – 7989
2021
Q4 		– Hold
0
– – – 7856

Other funds holding DRMA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return